| Addiction |
0 |
0.6 |
| Adolescent Medicine |
0 |
0.7 |
| Pain Management |
0 |
0.49 |
| Brain |
0 |
0.4 |
| Child |
0 |
0.4 |
| Epilepsy |
0 |
0.33 |
| Lysergic Acid Diethylamide |
0 |
0.3 |
| Anxiety Disorder |
0 |
0.24 |
| Depression |
0 |
0.22 |
| HIV Infection |
0 |
0.22 |
| Alcoholism |
0 |
0.21 |
| Alcohol Use |
0 |
0.2 |
| California |
0 |
0.2 |
| Hospital |
0 |
0.2 |
| Anxiety |
0 |
0.15 |
| Chronic Pain |
0 |
0.14 |
| Drug Abuse |
0 |
0.11 |
| Multiple Sclerosis |
0 |
0.11 |
| Post-Traumatic Stress Disorder |
0 |
0.11 |
| Sleep Disorders |
0 |
0.11 |
| Substance Abuse |
0 |
0.11 |
| Abuse |
0 |
0.1 |
| Insomnia |
0 |
0.1 |
| Muscle |
0 |
0.1 |
| Pain |
0 |
0.1 |
| Psychosis |
0 |
0.1 |
| Cognitive Impairment |
0 |
0.07 |
| Activism |
0 |
0.05 |
| AIDS |
0 |
0.05 |
| Cancer |
0 |
0.05 |
| Cannabinoids |
0 |
0.05 |
| Chemotherapy |
0 |
0.05 |
| Emesis |
0 |
0.05 |
| Hallucination |
0 |
0.05 |
| Hallucinogen |
0 |
0.05 |
| Health Administration |
0 |
0.05 |
| Impairment |
0 |
0.05 |
| Mild Cognitive Impairment |
0 |
0.05 |
| Nausea |
0 |
0.05 |
| Schizophrenia |
0 |
0.05 |
| Spasticity |
0 |
0.05 |
| Tourette Syndrome |
0 |
0.05 |
| Washington |
0 |
0.05 |
| Weight Loss |
0 |
0.05 |
| Weight Management |
0 |
0.05 |